Personal profile
Education/Academic qualification
Post Doctoral Fellow, Northwestern University Medical School
2017
Post Doctoral Fellow, University of Texas MD Anderson Cancer Center
2013
Doctor of Philosophy, The Hong Kong University of Science and Technology
2008
BS - Foreign Institution, The Hong Kong University of Science and Technology
2003
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Targeting TRIM28-mediated Metabolic-Epigenetic Crosslink to Treat Metastatic Castration-Resistant Prostate Cancer
Fong, K. W. (PI) & Liu, J. (CoI)
Mike Slive Foundation for Prostate Cancer Research
1/1/26 → 12/31/26
Project: Research project
-
Targeting RSK-TRIM28-E2F1 Axis Overcomes CDK4/6 Inhibitor Resistance in Lethal RB1 Deficient Prostate Cancer
Fong, K. W. (PI), Allison, D. (CoI), Liu, J. (CoI) & Liu, X. (CoI)
9/1/23 → 9/1/26
Project: Research project
-
The Role of SETDB1 in Prostate Cancer
Fong, K. W. (PI), Allison, D. (CoI), Liu, J. (CoI), Liu, X. (CoI) & Xiao, G.-Y. (CoI)
4/1/26 → 3/31/30
Project: Research project
-
Pilot: Determining the Role of AR-Repressed Gene, CCDC83 in Conferring Anti-Androgen Resistance in Prostate Cancer
Fong, K. W. (PI)
12/1/22 → 11/30/23
Project: Research project
-
TRIM28 fuels prostate cancer growth through SETDB1-mediated epigenetic silencing of androgen metabolic genes UGT2B15 and UGT2B17 (Project #3)
Fong, K. W. (PI), Moseley, H. (CoI) & Weiss, H. (CoI)
National Institute of General Medical Sciences
8/13/21 → 12/31/21
Project: Research project
-
RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression
Kim, M., Liu, J., Zhang, Y., Wang, R., Goettl, R., Grasso, J., Allison, D. B., Wang, C., Gao, T., Liu, X. & Fong, K. W., Jun 16 2025, In: Journal of Clinical Investigation. 135, 12, e185119.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
Zhang, Y., Fong, K. W., Mao, F., Wang, R., Allison, D. B., Napier, D., He, D., Liu, J., Zhang, Y., Chen, J., Kong, Y., Li, C., Li, G., Liu, J., Li, Z., Zhu, H., Wang, C. & Liu, X., Jul 23 2024, In: Cell Reports. 43, 7, 114431.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
Gritsina, G., Fong, K. W., Lu, X., Lin, Z., Xie, W., Agarwal, S., Lin, D., Schiltz, G. E., Beltran, H., Corey, E., Morrissey, C., Wang, Y., Zhao, J. C., Hussain, M. & Yu, J., Aug 1 2023, In: Journal of Clinical Investigation. 133, 15, e166248.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Downregulation of EZH2 inhibits epithelial–mesenchymal transition in enzalutamide-resistant prostate cancer
Zhang, Z., Wang, X., Kim, M., He, D., Wang, C., Fong, K. W. & Liu, X., Nov 2023, In: Prostate. 83, 15, p. 1458-1469 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
Lu, X., Fong, K. W., Gritsina, G., Wang, F., Baca, S. C., Brea, L. T., Berchuck, J. E., Spisak, S., Ross, J., Morrissey, C., Corey, E., Chandel, N. S., Catalona, W. J., Yang, X., Freedman, M. L., Zhao, J. C. & Yu, J., May 2022, In: Nature Genetics. 54, 5, p. 670-683 14 p.Research output: Contribution to journal › Article › peer-review
Open Access79 Scopus citations